DnB Asset Management AS cut its stake in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 62.6% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 30,622 shares of the company’s stock after selling 51,356 shares during the period. DnB Asset Management AS’s holdings in DocuSign were worth $1,564,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Meiji Yasuda Asset Management Co Ltd. lifted its position in DocuSign by 1.9% during the 2nd quarter. Meiji Yasuda Asset Management Co Ltd. now owns 8,965 shares of the company’s stock worth $514,000 after acquiring an additional 164 shares in the last quarter. Integrated Wealth Concepts LLC lifted its position in DocuSign by 3.8% during the 4th quarter. Integrated Wealth Concepts LLC now owns 5,009 shares of the company’s stock worth $278,000 after acquiring an additional 182 shares in the last quarter. Utah Retirement Systems lifted its position in DocuSign by 0.6% during the 2nd quarter. Utah Retirement Systems now owns 34,587 shares of the company’s stock worth $1,984,000 after acquiring an additional 200 shares in the last quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC increased its holdings in DocuSign by 440.0% during the 1st quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 270 shares of the company’s stock worth $28,000 after purchasing an additional 220 shares during the last quarter. Finally, US Bancorp DE increased its holdings in DocuSign by 1.7% during the 1st quarter. US Bancorp DE now owns 14,529 shares of the company’s stock worth $847,000 after purchasing an additional 247 shares during the last quarter. 77.96% of the stock is owned by institutional investors and hedge funds.
DocuSign Price Performance
NASDAQ:DOCU opened at $43.69 on Wednesday. DocuSign, Inc. has a 12-month low of $39.57 and a 12-month high of $69.45. The firm has a market capitalization of $8.88 billion, a P/E ratio of -485.39, a P/E/G ratio of 8.11 and a beta of 0.90. The business has a 50 day simple moving average of $50.00 and a 200 day simple moving average of $52.59.
Analyst Ratings Changes
Several equities research analysts have issued reports on DOCU shares. Citigroup lifted their price objective on DocuSign from $81.00 to $87.00 and gave the stock a “buy” rating in a report on Wednesday, September 13th. Morgan Stanley lifted their price objective on DocuSign from $49.00 to $51.00 and gave the stock an “underweight” rating in a report on Friday, September 8th. Royal Bank of Canada restated a “sector perform” rating and set a $59.00 price objective on shares of DocuSign in a report on Friday, September 8th. HSBC initiated coverage on DocuSign in a report on Friday, September 15th. They set a “reduce” rating and a $42.00 price objective on the stock. Finally, UBS Group boosted their price target on DocuSign from $44.00 to $48.00 and gave the company a “sell” rating in a report on Friday, September 8th. Five equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, DocuSign presently has an average rating of “Hold” and a consensus target price of $61.43.
Get Our Latest Research Report on DocuSign
Insider Activity at DocuSign
In other DocuSign news, insider Stephen Shute sold 100,315 shares of the business’s stock in a transaction on Thursday, July 6th. The stock was sold at an average price of $49.20, for a total transaction of $4,935,498.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other DocuSign news, insider Stephen Shute sold 100,315 shares of the business’s stock in a transaction on Thursday, July 6th. The stock was sold at an average price of $49.20, for a total transaction of $4,935,498.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Enrique T. Salem sold 2,500 shares of the business’s stock in a transaction on Friday, July 7th. The stock was sold at an average price of $50.02, for a total value of $125,050.00. Following the transaction, the director now owns 156,140 shares of the company’s stock, valued at approximately $7,810,122.80. The disclosure for this sale can be found here. Insiders sold 116,421 shares of company stock worth $5,652,545 in the last 90 days. 17.80% of the stock is currently owned by company insiders.
DocuSign Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides DocuSign e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories
- Five stocks we like better than DocuSign
- Trading Halts Explained
- Hold-It-Forever AutoZone Pulls into Buy Zone
- What is the price-to-earnings growth (PEG) ratio?
- Virtual Riches: 3 Stocks Leading the VR Revolution
- There Are Different Types of Stock To Invest In
- 5 eCommerce Companies that need to be on Your Watch List
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.
